Publications

  1. Stevens RJ, Ali R, Bankhead CR, Bethel MA, Cairns BJ, Camisasca RP, Crowe FL, Farmer AJ, Harrison S, Hirst JA, Home P, Kahn SE, McLellan JH, Perera R, Plüddemann A, Ramachandran A, Roberts NW, Rose PW, Schweizer A, Viberti G, Holman R. Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia. 2012 Oct;55(10):2593-603
  2. Nagrebetsky A, Larsen M, Craven A, Turner J, McRobert N, Murray E, Gibson O, Neil A, Tarassenko L, Farmer A. Stepwise self-titration of oral glucose-lowering medication using a mobile telephone-based telehealth platform in type 2 diabetes: a feasibility trial in primary care. 2013;7:123–34.
  3. Oke J, Farmer A, Neil A, et al. Monitoring young people with type 1 diabetes for diabetic nephropathy: Potential errors of annual ACR testing. Diabetes Res Clin Prac Published Online First: 8 January 2013. doi:10.1016/j.diabres.2012.12.010
  4. Taylor KS, Heneghan CJ, Farmer AJ, et al. All-Cause and Cardiovascular Mortality in Middle-Aged People With Type 2 Diabetes Compared With People Without Diabetes in a Large U.K. Primary Care Database. Diabetes Care Published Online First: 22 February 2013. doi:10.2337/dc12-1513
  5. Hirst JA, Farmer AJ, Dyar A, et al. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis. Diabetologia Published Online First: 15 March 2013. doi:10.1007/s00125-013-2856-6
  6. French DP, Wade AN, Farmer AJ. Predicting self-care behaviours of patients with type 2 diabetes: The importance of beliefs about behaviour, not just beliefs about illness. J Psychosom Res 2013;74:327–33.
  7. Nagrebetsky A, Jin J, Stevens R, James T, Adler A, Park P, et al. Diagnostic accuracy of urine dipstick testing in screening for microalbuminuria in type 2 diabetes: a cohort study in primary care. Fam.Pract. 2012: Sep.16;:–.
  8. Farmer AJ, Brockbank KJ, Keech ML, England EJ, Deakin CD. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med. 2012 Mar 21. doi: 10.1111/j.1464-5491.2012.03657.x.
  9. Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012;344:e486. doi: 10.1136/bmj.e486.
  10. Farmer A, Hardeman W, Hughes D, Prevost AT, Kim Y, Craven A, et al. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract. 2012 ;13:30.
  11. Nagrebetsky A, Griffin S, Kinmonth AL, Sutton S, Craven A, Farmer A. Predictors of suboptimal glycaemic control in type 2 diabetes patients: The role of medication adherence and body mass index in the relationship between glycaemia and age. Diabetes Res Clin Pract 2012 Jan 17. [Epub ahead of print]
  12. Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ. Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care 2012; 35:446-54.
  13. Hirst, J, Taylor, K, Steens, R, Blacklock C, Roberts, N, Pugh, C, Farmer, A, The impact of renin angiotensin-aldesterone system inhibitors on type 1 and type 2 diabetes patients with and without early diabetic nephropathy. Kidney International, 2010; Dec 21. doi: 10.1038/ki.2011.413.
  14. Lung TW, Hayes AJ, Hayen A, Farmer A, Clarke PM. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res 2011;
  15. Farmer AJ, Oke J, Stevens R, Holman RR. Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. Diabetes Obes Metab 2011; 13:1136-41.
  16. Blacklock CL, Hirst JA, Taylor KS, Stevens RJ, Roberts NW, Farmer AJ. Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis. Diabet Med. 2011; 28:1182-7.
  17. Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Participants’ experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study. Diabetic Medicine 2011; 28:543-8.
  18. Thanabalasingham G, Pal A,Selwood M, Dudley C, Fisher K, Bingley P, Ellard S, Farmer A, McCarthy M, Owen K. Systematic assessment of etiology in adults with young-onset type 2 diabetes is a successful strategy for identifying Maturity-onset diabetes of the young. Diabetes Care 2011 (in press)2012 Jun;35(6):1206-12. Epub 2012 Mar 19
  19. Lawton J, Jenkins N, Derbyshire J, Farmer AJ, Holman R, Hallowell N. Understanding outcomes in multi-centre trials: a qualitative investigation of the understandings, experiences and views of health professionals involved in a randomized insulin trial in the UK. Social Science and Medicine 2011
  20. Oke JL, Stevens R, Gaitskell K, Farmer A. Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model. Diabetic Medicine 2011: 2012 Feb;29(2):266-71
  21. Malanda UL, Bot SD, French DP, Kostense PJ, Wade AN, Dekker JM, Nijpels G, Farmer AJ. Experience of hypoglycaemia is associated with changes in beliefs about diabetes in patients with Type 2 diabetes. Diabet Med. 2011, doi: 10.1111/j.1464-5491.2011.03340.x.
  22. Lawton J, Jenkins N, Darbyshire JL, Holman RR, Farmer AJ, Hallowell N. Challenges of maintaining research protocol fidelity in a clinical care setting: a qualitative study of the experiences and views of patients and staff participating in a randomized controlled trial. Trials. 2011, 28(5):243-8.
  23. Kropff J, Selwood M, McCarthy MI, Farmer AJ, Owens KR. Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire (UK), Diabetologia 2011 54(5):1261-3.
  24. Al-Ansary LA, Farmer A, Hirst J, Roberts N, Glasziou P, Perera R, Price CP. Point-of-Care Testing for HbA1c in the Management of Diabetes: A Systematic Review and Meta-analysis. Clinical Chemistry 2011;57:568-76.
  25. Neil HA, Ceglarek U, Thiery J, Paul S, Farmer A, Holman RR. Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: A randomised placebo controlled factorial trial. Atherosclerosis 2010 doi:10.1016/j.atherosclerosis.2010.09.013
  26. Larsen ME, Turner J, Farmer A, Neil A, Tarassenko L. Telemedicine-supported insulin optimisation in primary care. J Telemed Telecare 2010 Sep 14. [Epub ahead of print]
  27. Owen KR, Thanabalasingham G, James TJ, Karpe F, Farmer AJ, McCarthy MI, Gloyn AL. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 2010 Sep;33(9):1919-24.
  28. Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, Jamtvedt G, Farmer A et al. Taking healthcare interventions from trial to practice.BMJ2010 Aug 13;341:c3852. doi: 10.1136/bmj.c3852.
  29. White HJ, Bettiol SS, Perera R, Roberts NW, Javaid MK, Farmer AJ. A systematic review assessing the effectiveness of interventions to improve persistence with anti-resorptive therapy in women at high risk of clinical fracture. Family Practice 2010 Dec;27(6):593-603.
  30. D'Arcy JL, Collapen H, Ebbs D, Grimwade P, Farmer A, Mant D, Prendegast B. Screening for Valve Disease in the UK Population: Preliminary Data from the OxVALVE Population Cohort Study. Cardiology 2010; 115: 261-262.
  31. Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Initiating insulin as part of the Treating to Target in Type 2 Diabetes (4-T) trial: A interview study of patients' and health professionals' experiences. Diabetes Care. 2010 Oct;33(10):2178-80
  32. Takahashi O, Farmer AJ, Shimbo T, Fukui T, Glasziou PP. HbA1c to Detect Diabetes Mellitus in Healthy Adults: When Should We Re-check? Diabetes Care. 2010 Jun 21. [Epub ahead of print]
  33. Pal A, Farmer AJ, Dudley C, Selwood MP, Barrow BA, Klyne R, Grew JP, McCarthy MI, Gloyn AL, Owen KR. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.   2010 Feb;33(2):252-7.
  34. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009 Oct 29;361(18):1736-47.
  35. Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia. 2009 Oct;52(10):1990-2000.
  36. Adler AI, Shaw EJ, Stokes T, Ruiz F; Guideline Development Group. Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance. BMJ. 2009 May 22;338:b1668. doi: 10.1136/bmj.b1668.
  37. Turner J, Larsen M, Tarassenko L. Neil, H, Farmer A. Implementation of telehealth support for patients with type 2 diabetes using insulin treatment: an exploratory study Informatics in Primary Care 2009; 17:47–53.
  38. Farmer AJ, Heneghan C, Barnett AH, Davidson MB, Guerci B, O'Kane M, Schwedes U, Perera R; Self-monitoring of blood glucose trialists collaboration Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: Protocol for a systematic review. Prim Care Diabetes. 2009 Apr 15. [Epub ahead of print]
  39. Farmer A, Wade A, French D, Simon J, Yudkin P, Gray A, et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.Health Technol Assess 2009; Feb;13(15):1-72.
  40. Hartweg J, Farmer AJ, Holman RR, Neil A. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 2009; Feb;20(1):30-8.
  41. Farmer A. Taking tablets for chronic illness: where next?. Chronic Illn 2008; Dec;4(4):235-8.
  42. Holman RR, Paul S, Farmer A, Tucker L, Stratton IM, Neil HA, et al. Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial. Diabetologia  2009;52:50-9.
  43. Bot S, Davis TME, Davis WA, Farmer A, Gagliardino JJ, Giorda C, et al. Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison. Diabetes Res Clin Pract 2008; Dec;82(3):e15-8.
  44. Farmer A, Balman E, Gadsby R, Moffatt J, Cradock S, McEwen L, et al. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events. Curr Med Res Opin 2008; Sep 30
  45. French DP, Wade A, Yudkin P, Neil H.A.W., Kinmonth AL, Farmer A. Self-monitoring of blood glucose changed non-insulin treated type 2 diabetes patients’ beliefs about diabetes and self-monitoring in a randomised trial. Diabetic Med 2008;25:1218-28.
  46. Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ, et al. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract 2008; Apr 11;9:20.
  47. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2008; Jan 23;(1)(1):CD003205.
  48. Neil HA, Perera R, Armitage JM, Farmer AJ, Mant D, Durrington PN. Estimated 10-year cardiovascular risk in a British population: results of a national screening project. Int J Clin Pract 2008; Sep;62(9):1322-31.
  49. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A, et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008; 05/24;336(7654):1177-80.
  50. Sturt JA, Whitlock S, Fox C, Hearnshaw H, Farmer AJ, Wakelin M, et al. Effects of the Diabetes Manual 1:1 structured education in primary care. Diabet Med 2008; Jun;25(6):722-31.
  51. Hartweg J, Gunter M, Perera R, Farmer A, Cull C, Schalkwijk C et al. Stability of soluble adhesion molecules, selectins, and C-reactive protein at various temperatures: implications for epidemiological and large-scale clinical studies. Clin Chem 2007;53:1858-60. 
  52. Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC. Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. N Engl J Med, 2007. 
  53. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth A-L, Neil HA, for the Diabetes Glycaemic Education and Monitoring Trial Group. Impact of self-monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335:132. 
  54. Campbell C, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, Guthrie B, Lester H, Wilson P, Kinmonth AL. Designing and evaluating complex interventions to improve health care. BMJ 2007; 334: 455-9. 
  55. Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 2007; 50: 250-8. 
  56. Hartweg, J, Farmer, AJ, Perera, R, Holman, RR, and Neil, HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007; 50: 1593-1602. 
  57. Arembepola C, Farmer A, Perera R, Neil HAW. Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. Atherosclerosis
  58. Farmer AJ, Kinmonth AL, Sutton S, Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Diabetic Medicine 2006; 23: 265-70. 
  59. Farmer AJ, Gibson O, Dudley C, Bryden K, Hayton P, Tarassenko L, Neil A. A randomised controlled trial of the effects of real-time telemedicine support on glycemic control in young adults with type 1 diabetes mellitus. Diabetes Care 2005; 28; 2697-702. 
  60. Farmer AJ, Gibson O, Dudley C, Bryden K, Hayton P, Tarassenko L, Neil A. A real-time, mobile phone based, telemedicine system to support young adults with type 2 diabetes. Informatics in Primary Care
  61. Farmer AJ, Doll H. In a randomized trial, outcomes were not affected by intensive follow up over one year. Journal of Clinical Epidemiology 2005; 58; 991-996. 
  62. Farmer A, Wade A, French D, Goyder E, Kinmonth AL, Neil A. The DiGEM trial protocol - a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. BMC Family Practice; 2005;6;25 
  63. Farmer A, Gibson O, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabetic Medicine 2005 22;1372-8. 
  64. Wendland E, Farmer AJ, Glasziou P, Neil A. Effect of alpha-linolenic acid on cardiovascular risks markers. Heart: 2006; 92; 166-9 
  65. P.M. Clarke, A.M. Gray, A. Briggs, A. Farmer, P. Fenn, R. Stevens, D. Matthews, I.M. Stratton  and R. Holman on behalf of the UK Prospective Diabetes Study (UKPDS) Group A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68): Diabetologia 2004;47;1747-59. 
  66. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM, Farmer A, Sandercock PAG, Dennis MS, Warlow CP, Bamford JM, Anslow P. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). The Lancet 2004;363;1925-1933.  
  67. Farmer AJ, Doll H, Levy JC, Salkovskis PM.  The impact of screening for Type 2 diabetes in siblings of patients with established diabetes. Diabetic Medicine 2003;20: 996-1004. 
  68. John JH, Ziebland S, Yudkin P, Roe L, Neil HAW, for the Oxford Fruit and Vegetable Study Group. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359:1969-74. 
  69. Gray, A., Clarke, P., Farmer, A., Holman R, R. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63) BMJ, 2002; 325: 860. 
  70. Lister A-M, Rode S, Farmer A, Salkovskis PM. Does thinking about personal health risk increase anxiety. Journal of Health Psychology 2002;7:409-14. 
  71. Farmer A, Montori V, Clar C, Dineen S. Fish Oil and type 2 diabetes. Cochrane Database of Systematic Reviews July 2000. 
  72. Montori V.M, Farmer A, Woolan P, Dinneen SF. Fish oil supplementation in type 2 diabetes. Diabetes Care 2000: 23:1407-1415. 
  73. Farmer AJ, Levy JC, Turner RC. Knowledge of risk of developing diabetes mellitus among siblings of type 2 diabetic patients. Diabetic Medicine 1999: 16; 233-237. 
  74. Goldstein LB, Farmer A, Matchar DB. Primary care physician-reported secondary and tertiary stroke prevention practices: a comparison between the United States and the United Kingdom. Stroke 1997; 2: 746-751.
  75. Shepperd S, Coulter A, Farmer A. Using interactive videos in general practice to inform patients about treatment choices: a pilot study. Family Practice 1995;12:443-7.
  76. Taylor MJO, Farmer A, Craig C. Women's knowledge of the contraceptive pill:  the results of a focus group. British Journal of Family Planning 1995; 21:27-29.
  77. Taylor MJO, Farmer A, Craig C. The focus group: is this an acceptable method of exploring women's knowledge of the oral contraceptive? British Journal of Family Planning 1995; 21:25-26.
  78. Verne J, Kettner J, Mant D, Farmer A, Mortenson N, Northover J. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer:  results of a randomized controlled trial. European Journal of Cancer Prevention 1993; 4:301-305.
  79. Farmer A. Practice guidelines: Lessons from America. BMJ 1993; 307:313-317.
  80. Attwood S, Bird R, Burch K, Casadei B, Coats A, Conway J, Dawes M, Ebbes D, Farmer A, Robinson J. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine . J Hypertens 1994; Sep;12(9):1053-60.
  81. Mant D, Fitzpatrick R, Fuller A, Farmer A, Verne J, Northover J. The experience of patients with false positive results from colo-rectal cancer screening. British Journal of General Practice 1991;41:135-6.
  82. Hunter W, Farmer A, Mant D. The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited. Family Practice 1991; 8:367-372.
  83. Farmer A, Coulter A. The organization of care for diabetic patients in general practice: influence on hospital admissions. British Journal of General Practice 1990; 40:56-58.
  84. Farmer A, Markus A. Family influences on the development of psychological problems in teenagers. Journal of Royal College of General Practitioner 1986; 36:522-24.

Last updated March 25th 2013.